• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.87% Nasdaq Up0.34%

    Novo Nordisk A/S (NVO)

    -NYQ
    44.12 Up 0.31(0.71%) 4:03PM EST
    |After Hours : 44.12 0.00 (0.00%) 5:36PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2012Dec 31, 2011Dec 31, 2008
    Net Income 3,787,000   2,986,000   1,827,728  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation -   -  462,759  
    Adjustments To Net Income90,000  671,000  253,551  
    Changes In Accounts Receivables -   -  (210,345)
    Changes In Liabilities -   -  227,211  
    Changes In Inventories -   -  (123,365)
    Changes In Other Operating Activities48,000  76,000   -  
    Total Cash Flow From Operating Activities 3,925,000   3,733,000   2,437,539  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(596,000)(537,000)(335,794)
    Investments(89,000)(34,000)88,307  
    Other Cash flows from Investing Activities(35,000)(33,000)(14,402)
    Total Cash Flows From Investing Activities (719,000) (604,000) (261,889)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid(1,368,000)(996,000)(529,653)
    Sale Purchase of Stock(2,102,000)(1,851,000)(837,969)
    Net Borrowings(89,000)(89,000)(28,994)
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities (3,559,000) (2,935,000) (1,396,615)
    Effect Of Exchange Rate Changes(1,000)(3,000)(379)
    Change In Cash and Cash Equivalents (353,000) 194,000   778,656  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.